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ABSTRACT 
 
 
Novel 125I Production and Recovery System. (August 2007) 
Adwitiya Kar, B.Sc., University of Calcutta; 
M.Sc., University of Calcutta 
Chair of Advisory Committee: Dr. Warren Dan Reece 
 
 
This research suggests ways of reducing contamination of iodine-126 in iodine-125 and 
lays out a simpler iodine-125 production technique to increase the yield. 
By using aluminum irradiation vessels the yield of iodine-125 produced by neutron 
irradiation of Xe-124 can be doubled compared to using stainless steel vessels. Because of 
increased yields irradiation times are shorter, the chance of I-126 contamination is reduced. 
Solidified iodine within the aluminum vessels can be extracted using 0.1 N sodium hydroxide 
solution, however the solution also reacts with the vessel walls. These impurities in the extracted 
solution are then removed by distillation that concentrates and purifies the extracted solution. 
High recovery, ranging from 88 to 96 percent, was typical for the experiments described. 
Gamma spectroscopic results suggest that the distillate is free from any impurities such as 
aluminum or sodium ions. Distillation can reduce the extracted solution to at least one third or 
less of its original volume. The work described here provides the basis for I-125 production at 
the Texas A&M Nuclear Science Center.
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INTRODUCTION 
 
 
There is an increasing need for iodine-125 in the world market for research, medical and 
diagnostic use. In radio-biological assays, I-125 is used as a tracer, often tagged to protein 
molecules and imaged by auto radiography. Its 35 keV gamma and 27 keV X- rays makes it a 
widely used brachytherapy source for prostrate cancer, breast cancer and brain tumor treatments. 
Recent journal articles and reports from a Department of Energy (DOE) expert panel for last few 
years have pointed out that there is limited domestic availability of radionuclides for laboratory 
and clinical research during the early stages of developing and testing new radiopharmaceutical 
products (DOE 1999, Tenforde 2004). At present, a considerable amount of iodine-125 comes to 
US from international sources (Studsvik 1998, ANS 2004). Furthermore a report from DOE’s 
symposium in 2004 showed McClellan/UC Davis as the only producer of I-125 under DOE’s 
isotope program in U.S. (OSTI 2004). This is not enough to support the domestic demand of 
iodine-125. The USA alone accounts for about 36000 procedures requiring radioisotopes. This 
includes medical procedures such as brachytherapy, radioactive tracing as well as diagnostic 
procedures like radio-immuno-assay (RIA), all of which depend to some extent on the supply of 
iodine-125. 
 The current processes followed by most companies producing I-125 from Xe-124 are 
have problems. Most producers use stainless steel irradiation cylinders for activating Xe-124 
because iodine’s chemical reactivity makes the removal of iodine from the decay cylinder 
challenging for anything other than stainless steel. However, stainless steel reduces the neutron 
flux by half and lowers the yield. This prolongs the irradiation time for stainless steel containers 
that in turn can increase the level of I-126. Iodine-126 is an undesired contaminant in I-125. An 
alternative to this is to use aluminum irradiation cylinders. Aluminum cylinders are essentially 
transparent to thermal neutrons and double the flux compared to stainless steel. Nevertheless, it 
is difficult to extract iodine from aluminum cylinders because of aluminum’s reactivity with 
extracting solution such as sodium hydroxide. The chemical product of the reaction contaminates 
the extracted iodine solution. 
 
This thesis follows the style of Health Physics. 
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One objective of this research is to suggest ways of reducing such contaminants and lay 
out a simpler I-125 production technique to increase the yield. McMaster’s production process, 
for example uses stainless steel capsules for Xe-124 irradiation, transfers the irradiated gas to a 
second stainless steel capsule where it decays to I-125. The process of transferring of highly 
radioactive Xe-125 is complicated and has to be carried out underwater within a second vessel to 
preclude escape of the radioactive gasses. In addition, reusing the irradiation chamber for 
succeeding cycles raises the chance of making I-126 from any I-125 remaining from previous 
cycles. Instead, we suggest using a single cylinder for irradiation and decay obviating the need 
for a separate decay chamber. Using a new aluminum cylinder for every cycle or aggressively 
cleaning the single cylinder can reduce the chance of I-126 contamination resulting from any in 
buildup of I-125. Besides avoiding a complex valve system, this method eliminates the risk 
associated with a transfer process like McMaster’s. As mentioned before, aluminum irradiation 
canisters, unlike stainless steel, are essentially transparent to thermal neutrons and allow a higher 
thermal flux during irradiation. This in turn reduces the irradiation time for a desired yield and 
can help in limiting the possibility of I-126 formation from I-125. 
Another objective of this research was to devise a suitable method for extracting plated 
iodine-125 from aluminum cylinders. Experimental results suggest that 0.1N sodium hydroxide 
can be used as an extracting solution for recovering iodine-125. Sodium hydroxide etches the 
walls of the aluminum and extracts the iodine along with it. The aluminum hydroxide formed as 
a result of aluminum’s reaction with sodium hydroxide renders the recovered solution unusable 
without further purification. The third objective of the research was to find a way to concentrate 
and purify the extracted I-125. The current radiopharmaceutical market typically sells I-125 as 
sodium iodide after being recovered from the irradiation cylinders with sodium hydroxide 
solution. The target specific activity is typically 1 Ci/ml and this complicates the removal of the 
iodine from the vessel because of the small volumes of solute that can be used.  No one has 
published procedures to concentrate the solution of I-125 after its removal from the irradiation 
cylinders. We suggest using distillation to purify and concentrate the recovered solution. The 
main part of the research effort was to work out the details associated with iodine distillation. 
The findings suggest that distillation of 30ml of solution can result in distillate of about 7ml 
while carrying over 90% of the iodine. Distillation therefore can reduce the solution to almost 
one-third or less of its original volume. Thus, distillation serves both as a means of increasing of 
the I-125 concentration and removes impurities such as sodium and aluminum ions. 
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THEORY 
 
 
The history of iodine started when Bernard Courtois accidentally discovered it in the 
1800s. Since then iodine has become an important element in medicine, photography, dyes, and 
industry. Only one isotope of iodine, I-127, occurs naturally. The other iodine isotopes are 
artificial and are made in a reactor or a cyclotron.  Iodine is similar with other group VII 
elements chlorine, fluorine and bromine and like all halogens forms a diatomic molecule.  
However iodine is the least reactive of all halogens and has the special property of sublimation. 
Iodine has a meting point of 113oC and on heating turns into vapor without the intermediacy of 
liquid. It has a high vapor pressure and plates out as crystals on cooling. The vapor pressure of 
iodine, shown in Table 1, increases rapidly with temperature making it an extremely volatile 
element. Many of the measures adapted in the present research are directly related to this 
particular property of iodine. Since the chemistry of naturally occurring I-127 is the same as any 
of its radioisotopes, the reader should be aware of some basic chemical reactions of iodine in 
order to understand the analytical methods applied in this research. 
 
 
Table 1 Change in vapor pressure with temperature. 
 
 
 
 
Iodine dissolves slowly in water but dissolves faster in a solution of potassium iodide 
because of the formation of tri-iodide ions. 
2 3I I I
− −+ =        (1) 
The excess of iodide in the potassium iodide in the solution displaces the equilibrium 
from left to right. Iodide ions have much less vapor pressure than iodine and presence of tri-
Pressure 
(Torr) 
10-5 10-4 10-3 10-2 10-1 1 10 100 760 
Temperature 
(0C) 
-61.3 -46.9 -30.2 -10.8 12.1 39.4 73.2 115.8 182.8 
  
4 
iodide ions reduces the volatility of iodine in the solution. Iodine can act as an oxidizing or 
reducing agent and has an oxidation potential of -0.53 volts. Equation 2 shows the reversible 
reaction of an iodine-iodide system. Iodine acts as oxidizing agent for substances with an 
oxidation potential much lower than that of the iodine-iodide system. 
 I2 + 2e- = 2I-  (2)                                                             
On the other hand iodide exerts a reducing action upon strongly oxidizing systems, with the 
formation of equivalent amount of iodine. Oxidizing agents like hydrogen peroxide (H2O2) react 
with iodide in an acidic medium to form iodine according to the reaction: 
H2O2 + 2I- + 2H+  I2 + 2H2O   (3)                                                      
The oxygen content of hydrogen peroxide is decreased during reduction. In such cases, 
the oxidation potential increases as a function of hydrogen ion concentration in the solution 
(Kolthoff et al 1952). This is because hydrogen ions take part in the reduction process and, as a 
result, raise the capability of hydrogen peroxide to accept electrons. Although the oxidation 
potential of the iodine-iodide system is virtually independent of the pH of the solution, for higher 
alkaline solution like sodium hydroxide (NaOH) with pH above 8, iodine reacts with hydroxyl 
ions to form hypoiodite and iodide. The hypoiodite is extremely unstable and is rapidly 
transformed into iodates: 
           I2 + 2OH-            IO- + I- + H2O (4)                                                              
          3IO-   2I- + IO3-                                              
Upon reaction with potassium hydroxide, which is also strong base, iodine follows the same 
reaction as in Equation 4 to form potassium iodide and water, thereby reducing the volatility of 
the iodine in solution. Such reactions prove to be of great value for analytical methods of iodine 
estimation and have been used extensively in the present research. 
 
MEDICAL HISTORY AND RADIOISOTOPES OF IODINE 
 
Iodine entered medical history shortly after its discovery in 1820 when a Swedish 
scientist Jean François Coindet (1774–1834) suggested that iodine compounds might cure 
goiters, an enlargement of the thyroid gland in humans. But his studies were mostly 
observational and were not experimentally tested until Gaspard Adolph Chatin (1813–1901) 
began his extensive series of iodine analyses. In 1833 a French scientist named Jean 
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Boussingault (1802-1887) also recommended the use of dietary iodine for the prevention of 
goiter but both Chapin’s and Jean’s method of treatment was confirmed by a German chemist 
Eugen Baumann (1846-1896) in 1896. Baumann discovered that the thyroid gland was rich in 
iodine and also determined that the thyroid was the only tissue containing iodine (Rosenfield 
2000). Just two years later, Austrian psychiatrist, Julius Wagner von Jaurreg (1857-1940), 
established that goiter could be prevented by taking iodine tablets regularly and proposed that 
iodized salt be sold in areas where goiter was widespread. This made iodine a very sought after 
element and soon it gained a widespread acceptance in treating hyperthyroidism. 
Perhaps because iodine was so successful in treating goiters, the idea of using iodine to 
treat other diseases such as thyroid related cancers developed in 1900s with the discovery and 
development in the field of radioactivity. The first conscious urge to make radioactive iodine 
isotopes probably arose around 1934 when Enrico Fermi reported the production of several 
radioisotopes with small half-life in his laboratory (Fermi 1934). The paper was published in the 
reputed English journal ‘Nature’ and energized the Physics world to produce artificial radio-
isotopes that would be of value in health and medicine. In 1937 a group of scientist headed by 
Robley Evans in MIT produced I-128 by bombarding ethyl iodide with neutrons (Hertz et al 
1938, Chapman 1983) and in 1939 published a paper on the role of I-128 in thyroid physiology. 
Around the same time in 1938, I-131 was first produced at the Lawrence- Berkeley University of 
California by using Lawrence’s cyclotron. In a bid to produce radioisotopes with shorter half-life 
that can be used in medicine without many side effects, Glenn Seaborg and Jack Livingood 
bombarded tellurium with deuterons in the lab's 37-inch cyclotron producing I-131 (Livingood 
1938).Of the 35 isotopes of iodine that can be produced artificially, I-131 was the first isotope to 
be used in medicine and since has become the most popular in treating thyroid and other types of 
cancers. But interests soon turned to other low energy emitting radio-isotopes of iodine and this 
led to production of iodine-123 and iodine-125. I-123 replaced I-131 in radio-imaging and it was 
not long before the medical community started looking into I-125’s feasibility in curing prostrate 
and breast cancers along with its use in radioimmunoassay.  
 
PRODUCTION OF IODINE-125 AND MARKET DEMANDS 
 
Iodine-125 was first produced by Allen Reid and Albert Keston in 1946 (Stabin ) using a 
cyclotron. The usual method was to bombard natural Te in a cyclotron with 14 MeV deuterons. 
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Since natural tellurium is a mixture of eight different nuclides, contamination from radio-iodines 
such as I-131 and I-126 would occur. I-125 was the longest living contaminant and it could be 
separated by allowing the product to decay for months after formation (Myers 1984). However, 
this method was inconvenient and could not be used profitably for a steady supply of iodine-125 
in the world of medicine. In 1960 in another paper published in the ‘New Journal of Nuclear 
Medicine’ Myer and his colleagues suggested that I-125 might also be produced from Xe-124 
following the sequence: 
,124 125 125( , ) ECXe n Xe Iβγ +→  
He conjectured that because a neutron rich isotope will be formed, the procedure can be 
carried out in a reactor instead of a cyclotron and noted that even if Xe-124 is only 0.096% 
abundant such a reaction might be possible because of the high absorption cross section of Xe-
124 to thermal neutrons. By this process xenon-124 absorbs a thermal neutron undergoing an (n, 
γ) reaction in which a new isotope Xe-125 is produced. Xe-125 which has a 16.9 hr of half-life 
will in turn undergo electron capture (EC) and beta plus decay (β+) to produce iodine-125. The 
changes in a nucleus following a beta plus decay and electron capture are explained in equations 
5 and 6.  
 p+                n0 + e+ + νe   (5)                                                            
 p+ + e-                n0 + νe                                                                                                                           (6) 
In both cases the new isotope will carry the same mass number but a different atomic 
number than its parent. The iodine-125 formed will now undergo electron capture and decay to 
stable tellurium-125 completing the radioactive decay process. Soon after Myer’s proposition in 
1960, Lathrop and Harper (1961) explored this method of iodine-125 production (Harper at al 
1963). They irradiated natural xenon (Xe-124 0.095%) gas in a Zircaloy irradiation vessel using 
the ANL CP5 reactor (Lathrop and Harper 1963). Apart from the contamination from Cs-137 
which resulted from Xe-136 in the natural Xe-124, another possible side reaction seemed to be 
the formation of iodine-126 from I-125. In order to be certain Lathrop and Harper carried out a 
series of experiments to determine the neutron activation cross sections of xenon-124 and iodine-
125 and soon confirmed chances of heavy contamination in I-125 with I-126. After studying 
their data of the neutron absorption cross section for the two nuclides (reproduced in Table 2) 
they concluded that iodine-125’s high neutron activation cross section increases its possibility of 
a neutron capture during the irradiation of Xe-124. But the authors also pointed out that because 
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iodine-126 arises as secondary product from iodine-125, I-126 contamination could be prevented 
to a great extent by irradiating huge of quantities of Xe-124 for a short period of time.  
 
 
 
Table 2 Neutron activation cross sections from 124Xe (n, γ) 125Xe and 125I (n, γ) 126I in barns 
(Lathrop and Harper 1963). 
 
 
 
 
 
 
 
 
 
 
The current thermal neutron cross section for Xe-124 is about 168 barns and the thermal 
cross section for I-125 is 900 barns with a 14,000 barn resonance integral. Harper’s production 
method was a milestone in the history of radioactive I-125. Finally there was chance of 
producing of iodine-125 free from other radioactive contaminants like I-131 and I-126 and 
provided a profitable opportunity for using it in methods such as radioimmunoassay (RIA). 
Researchers soon realized that I-125’s 60-day half-life over I-131’s 8 day half-life would prove 
advantageous in studying protein structures and function and its low energy gamma could be 
effectively used in autoradiography and interstitial radiation therapy. But to be used in iodination 
of proteins and as radioactive seeds, the specific activity of the radioactive source was of primary 
importance. When producing iodine-125 from Xe-124 the specific activity of I-125 could be 
decreased by the contamination from iodine-126. When xenon-124 is irradiated it initiates a 
chain of side reactions shown in Figure 1. The main side reactions arising from the process were 
two double neutron captures and a direct neutron capture (Martinho et al 1984). 
125I (n, γ) 126I (n, γ) 127I 
125Xe (n, γ) 126Xe (n, γ) 127Xe     EC          127I 
 
  
Pile neutron activation cross section 
Target  Xe-124 (σ) I-125 
 ( σ) 
      
Xe-124 169   
Xe-124 179   
Xe-124…I-125 173 1160 
Xe-124…I-125 175 1138 
I-125   1180 
I-125   1110 
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Figure 1 Growth and decay of nuclides arising from neutron irradiation of natural xenon. 
 
 
Because the maximum specific activity and the minimum radionuclide contamination 
depended on the branching reactions, the neutron flux, the time of irradiation and the decay time, 
high specific activity could only be achieved by a proper planning of the radioisotope production 
scheme. Martinho et al. addressed the problem by using the computer program ISOTOP to 
graphically show the changes in iodine-125 activity and I-125 radionuclide contamination as a 
function of irradiation time for different thermal neutron fluxes. He studied iodine-125 activities 
as a function of irradiation time for changing thermal neutron fluxes as well as iodine-125 
radionuclide contamination as a function for irradiation time for varying fluxes and presented his 
observations as shown in Figures 2 and 3.   
Apart from controlling the time and the flux there were other concerns in making iodine-
125. Using natural xenon for irradiation raised the level of contaminants such as Cs-137 and Cs-
134. Since natural xenon is a mixture of several isotopes, its irradiation produced unwanted 
radionuclides such as Cs-137. But such problems were soon resolved and the industry quickly 
replaced natural xenon with 99.9% enriched xenon-124.This cut down the percentage of other 
isotopes of xenon and restricted the contamination to negligible quantities. Also as already 
suggested by Harper, irradiation of huge quantities of enriched Xe-124 in a short period of time 
with a thermal fluence roughly around 1013 helped to limit the production of I-126 to a 
considerable extent. In the early 90s with the advancement of computers such complex 
calculations were made relatively easy and now various computer programs such as MCNP are 
125Te 
125I 
125Xe 
126Te 
126I 
126Xe 
127I 
127Xe 
128Te 
128I 
128Xe 
124Xe 
σ 
σ σ σ 
λ 
σ 
λ 
   λ 
σ 
σ 
λ λ
    λ    λ 
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being used to calculate optimum irradiation conditions for a desired specific activity of the 
isotope.  
 
 
 
Figure 2 Iodine-125 activity as a function of irradiation time for different thermal neutron fluxes. 
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Figure 3 Iodine-125 radionuclide contamination as a function of irradiation time for different 
thermal neutron fluxes. 
 
 
After optimizing the irradiation procedures, a suitable process must be developed to 
recover the iodine-125 produced from Xe-125.The recovery of I-125 from the irradiation vessel 
has not been easy since the process’s conception. For a radionuclide that sublimes on the wall of 
the irradiation vessel and has a high vapor pressure, it was best recovered by Lathrop and Harper 
in 1961using potassium bisulphite adjusted to pH 7-8 with potassium hydroxide solution (Harper 
et al 1963). However, because of the reaction of the alkali with the walls of the irradiation vessel, 
the recovered solution wasn’t useful for medical applications. Since then the technique of I-125 
recovery has changed based on the market demands and technical feasibility. To minimize 
contamination, today most I-125 producers use stainless steel as an irradiation vessel. Since 
stainless steel has minimal reaction with sodium hydroxide, the standard practice is to recover 
the iodine-125 using an aqueous solution of sodium hydroxide and ship it as a sodium iodide 
solution. 
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At the Nuclear Science Center continuing efforts have been made to develop novel 
techniques in iodine-125 production and recovery. Interest in this research has largely been 
fueled by the current market requirements for iodine-125. In the last few years the use of iodine-
125 has increased as the source in brachytherapy seeds for cancer and in treatment of breast 
tumors and as a source for eye plaques. Although initially overshadowed by iodine-131, I-125 
has become one of the most used radioisotopes of our time. Because of its low energy gamma, I-
125 seeds are now being extensively used in interstitial tissue irradiation, in treating carcinomas 
of small glands such as the thyroid and prostrates. New innovative techniques are also calling for 
pure iodine-125 with high specific activity rather than its solution in sodium hydroxide. None of 
the major pharmaceutical suppliers have so far claimed to have produced iodine-125 in such 
form. Nowhere in the current literature is a suitable method for concentrating the I-125 solution 
obtained from the irradiation vessel. It is this lack that motivates the search for a new technique 
to produce iodine-125 solutions with high specific activity.  
A shortage in market supply against demands of I-125 has acted as another incentive for 
the present endeavor.  Current journal papers and Department of Energy’s (DOE) symposia have 
consistently pointed out that the United States market is facing a shortage in radionuclide supply 
compared to demand. A review of the sales of pharmaceutical products by the consulting firm 
Frost and Sullivan from 1998 to 2002 has showed that the compound annual revenue growth rate 
of the total United States radiopharmaceutical market will be 10.2% during the period 2001–
2008 (Tenforde 2004). Recent journal papers and reports from a DOE expert panel for last few 
years have continuously stressed on the problem of limited domestic availability of radionuclides 
for laboratory and clinical research during the early stages of developing and testing new 
radiopharmaceutical products (DOE 1999). In 1998 an expert panel assembled by DOE was 
formed to monitor the nation’s isotope program, to maintain a steady isotope supply as per 
demand. But subsequent reports through 2005 have shown that DOE is facing a crisis in 
providing radioisotopes for research and medicinal purposes (DOE 2005). This supply shortage 
fuels a large import rate from international companies (Adelstein et al 1995, Nordion 2007). 
Studsvik, partnered with McMaster claims to be the second largest producer of iodine in the 
world (Studsvik 2004) and is providing most of I-125 required by the US market. Furthermore, a 
report from DOE’s symposium in 2004 had shown McClellan/UC Davis as the only producer of 
I-125 under DOE’s isotope program in United States. U.C Davis has currently stopped iodine-
125 production leaving foreign companies to be the only suppliers of iodine-125 in United 
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States.  All these statistics has prompted the Nuclear Science Center to take an avid interest in 
producing iodine-125. 
 
PRODUCTION METHODS OF IODINE-125 BY MAJOR COMPANIES 
 
A literature review of the United States patent on iodine-125 production from 1976 was 
carried out in order to gain an insight into the current production methods utilized by the 
companies holding U.S patents. The search revealed that McMaster University reactor of Canada 
to be the sole patent holder in iodine-125 production and recovery methods (Hassal et al 1997) in 
United States. Other references indicate that the Swedish company Studsvik utilizes its R2 
reactor at Sweden to produce Iodine-125, and supplies iodine-125 in U.S through a partnership 
with the McMaster. MDS Nordion, the Canadian company is also a supplier of iodine-125. 
Although their production and recovery method has not been published, the radiopharmaceutical 
data shows that Nordion carries out dry distillation of the target to recover iodine-125 (Nordion 
2007) and the iodine ships as a solution in sodium hydroxide.  
Iodine production at McMaster has been described in detail in U.S patent 5633900. The 
McMaster Nuclear Reactor (MRC) uses a thermal flux of 1012 cm-2s-1 to irradiate Xe-124 in a 
stainless steel irradiation vessel. Figure 4 is a schematic reproduction of their production system 
explained in US patent 5633900. In this method , xenon-124 is transferred cryogenically into the 
irradiation vessel from storage of Xe-124. At the end of irradiation the decay of Xe-125 is 
moved to a second chamber connected to the irradiation vessel through a system of valves. The 
second chamber is detachable and is transferred to safe holding to keep iodine-125 away from 
neutron fluence. Once the iodine-125 is formed, the second chamber is attached to a vessel of 
degassed solution of NaOH and hydroxide solution is allowed to flow into the second chamber 
by a vertically attached needle through an opening controlled by a valve. The entire chamber is 
then inverted such that hydroxide solution is accumulated near the valve and the iodine-125 on 
the wall of the chamber is dissolved by refluxing the sodium hydroxide solution.  
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Figure 4 Iodine-125 production scheme at Mc Master (US 5633900). 
 
 
Although McMaster’s production system has been in operation since 1993, their method 
of production suffers apparent engineering problems. The method of gas transfer between the 
two chambers is complicated and has to be carried out in a tightly controlled environment. For a 
one week cycle, the  McMaster irradiates 5 grams of Xe-124 for 15 hours per day for a period of 
three to five days. A problem with this method is that iodine-125 produced at the beginning of 
the week becomes I-126 contaminant at end of irradiation. Since McMaster re-uses the stainless 
steel irradiation chamber, the residual I-125 plated inside the chamber from the first irradiation 
contributes to produce iodine-126 in subsequent cycles. This builds up and over time has the 
potential of exerting enough vapor pressure to contaminate the Xe-125 transferred into the decay 
chamber with iodine-126.  Moreover McMaster uses stainless steel as their material for 
irradiation vessel. Stainless steel has a high absorption cross section for thermal neutron and can 
reduce the flux to almost half requiring a longer irradiation time to produce the desired iodine 
activity. This can lead to higher levels of I-126 and eventually defeat the purpose of transferring 
Xe-125 into the second chamber away from any neutron flux to control the in growth of I-126.  
Extended 
valves 
Valves connecting 
two chambers 
Decay chamber 
Xe-125 to I-125 
Liquid 
Nitrogen 
Xe-124 chamber 
Xe-124 irradiation 
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The United States’s own iodine-125 production facility, an iodine-125 production 
assembly designed as a self contained unit, was first designed, fabricated and tested at the Los 
Alamos National Laboratory in 1992. But it was never tested with radioactive material and was 
eventually transferred to Sandia National Laboratories. Afterwards it was again sold to U.C 
Davis and in 2004 U C Davis became the sole producer of iodine-125 in the United States. The 
MNRC reactor of U C Davis produced iodine-125 from xenon-125 using the production 
assembly sold by Sandia Laboratories. Although this production method did not suffer from 
apparent problems of contamination with I-126, the recovery process from the decay chambers 
was complicated and had to be accomplished through network fine capillary tubes. A schematic 
portrayal of their production system in Figure 5 shows the way the iodine-125 was produced and 
recovered (Parma 1999)1. The assembly had a primary containment which was inside a 
secondary containment and was attached to a glove box. The primary containment as shown in 
Figure 5 was used for irradiation, transfer and decay of xenon-125 to iodine-125. The elution 
process from the decay chamber was done by allowing a flow of 0.005N sodium hydroxide 
solution through a system of capillary tubes leading directly to the product bottle. The decay 
storage vessel was surrounded by electrical heaters to keep the sodium hydroxide solution warm. 
One problem with such a method of recovery rose from the need to maintain a constant flow rate 
in the capillary tubes during the process of elution. A small accidental crack in any of the tubes 
meant a total dispersion of the radioactive solution and radioactive iodine vapors. Also because it 
was closed system there was a regular need of removing air from the product bottle to maintain 
the driving pressure. Apparently, this whole method of iodine production and recovery did not 
work out as planned and by 2006 U C Davis discontinued their iodine-125 production unit. 
 
 
                                                     
1
 “1-125 Production Assembly Design Specifications and Operating 
Theory,” Unpublished Report, Sandia National Laboratories, Albuquerque, NM, 
October 27, 1999. 
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Figure 5 Iodine-125 production unit at U C Davis. 
 
 
The research at NSC is centered on simplifying this process of transfer and recovery of 
pure iodine-125.The irradiation vessel at NSC is made of aluminum because aluminum is 
essentially transparent to thermal neutrons unlike stainless steel. The irradiation time at NSC can 
be kept reasonably short and this helps to prevent iodine-126 formation. Figure 6 gives a short 
schematic of the iodine-125 production at NSC. Comparing the scheme with the McMaster and 
U C Davis processes, it is evident that the NSC process is much simpler and does not require any 
complex containment. Use of a single chamber for irradiation and decay precludes the complex 
valve system needed for connecting two chambers as used by McMaster. Once the valves 1, 2, 3 
and 4 are opened a vacuum pump removes the air inside the aluminum irradiation vessel. After 
sufficient time valve 1 is closed, the aluminum cylinder is immersed in liquid nitrogen, and valve 
6 is opened allowing the flow of Xe-124 from its storage cylinder.  Xe-124 is now transferred 
cryogenically to the irradiation chamber solidifying inside the vessel. When the transfer is 
complete, the valves are closed and the tube containing the irradiation vessel is detached from 
the rest of the system. The irradiation vessel is now transferred to the core where it is irradiated 
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for about 14 hours to make Xe-125. At the end of irradiation the vessel is removed from the core 
to a safe storage away from neutron flux inside the pool. Here the Xe-125 decays to iodine-125.  
Table 3 shows the activity of xenon-125 at the end of irradiation and the also the activity 
from the gradual buildup of iodine-125 inside the irradiation vessel during decay of xenon-125 to 
iodine-125. 7.65 grams of Xe-124 produces 546 Ci of Xe-125 after 14 hours of irradiation. Since 
the irradiation time at NSC is less than 17 hrs there is much less possibility of producing iodine-
126 from iodine-125. A calculation of the tm value which is the time when the daughter and 
parent’s activity equals show that in about 5 days following end of irradiation the activity of Xe-
125 equals that of I-125. 
 
 
Table 3 Activities of Xe-125 and I-125 during decay. 
Days 
Xe-125 activity in 
Ci 
I-125 activity in 
Ci 
   
0 546.3128 0 
0.01 541.0236 0.0627 
0.05 520.375 0.3074 
0.1 495.6688 0.6 
0.5 335.8863 2.4869 
0.7 276.4984 3.1844 
1 206.3128 4.0016 
2 78.0629 5.4684 
3 29.5085 5.9774 
4 11.1545 6.1250 
5 4.2165 6.1365 
6 1.5939 6.097 
7 0.6025 6.0388 
8 0.2277 5.974 
9 0.0861 5.9071 
10 0.0325 5.84 
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Figure 6 Proposed scheme for I-125 production at NSC. 
 
 
An activity curve showing the in growth of the daughter iodine-125 from its shorter-
lived parent xenon-125 is shown in Figure 7. Following the table and the exponential decay 
curve note that between 4 and 5 days post-irradiation the activity of I-125 builds up and reaches 
a maximum when the activity of iodine-125 equals the activity of xenon-125. This is the 
maximum amount of iodine-125 that can be recovered from a single irradiation cycle. Although 
the activity of iodine-125 starts falling thereafter, the iodine is not extracted until the activity of 
Xe-125 falls to very low levels. This ensures proper practice of ALARA and limits the chances 
of iodine-126 contamination for the next irradiation cycle. A 10 day decay time is suggested 
before iodine-125 is recovered. At the end of 10 days the irradiation vessel is removed from the 
pool and attached to the system shown in Figure 6. The system is evacuated and the Xe-124 
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storage vessel is now placed in liquid nitrogen.  Valves 4,3,2,6 are opened and Xe-124 and a 
small amount of Xe-125 remaining in the irradiation vessel is transferred back into the storage 
vessel for reuse in subsequent irradiation cycles. Once the gas is transferred, valves 4, 3, 2, 6 are 
closed; the tube connected to the irradiation vessel is detached from the rest of the system and is 
transported to the glove box for extraction and distillation. 
 
 
 
 
Figure 7 Quantitative relationship between activity vs. time for Xe-125 and I-125. 
 
 
RECOVERY METHOD FOR IODINE-125 
 
This research centers on finding a suitable method of recovering iodine-125. The 
concentration of the iodine-125 available in the market is low and can be improved. A search 
into iodine-125 specifications data of the current suppliers reveals that McMaster sells (800-
1200) mCi of iodine ml-1 and Nordion, has three ranges of concentration, the highest being 500 
mCi ml-1 and the lowest being less than 200 mCi ml-1. This research shows that a high yield of 
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pure and concentrated iodine-125 is possible with distillation. Since iodine has a high vapor 
pressure, a considerable amount of iodine can be recovered with minimum amount of water in a 
short period of time. So the distillate obtained would be pure iodine-125 dissolved in a small 
amount of water distilled over with the iodine vapors. Although distillation of iodine has been 
attempted in the past, it has not been applied on an industrial scale for radioactive iodine 
recovery. In the past distillation has been used for separating carrier free iodine-125 from 
irradiated tellurium dioxide in which the aluminum capsule containing the target was dissolved 
in a mixture of aqueous sodium hydroxide and sodium nitrate (Khan et al.1977). The dioxide 
was then dissolved in concentrated nitric acid and iodine distilled into sodium hydroxide 
solution.  
At the Nuclear Science Center the aim is to keep the distillation procedure short and 
simple. The plated iodine inside the aluminum canisters is washed out with sodium hydroxide 
solution. However, the alkali will react with the aluminum and these contaminates are carried 
with the sodium hydroxide. This renders the solution unusable without further purification. 
Distillation of the extracted solution can remove these purities and can concentrate the iodine in 
the final solution.  This can prove to be a milestone in iodine recovery if properly conducted. 
The core of this research has been to work out the associated details of this distillation process. 
Analytical procedures like Neutron Activation Analysis (NAA) have been carried out to ensure 
that the distillate contains no other impurities such as aluminum or sodium. Iodine has a 
tendency to plate out on the condenser of the distillation unit during its passage to the collector 
vessel. This research has found ways to improve the distillation procedure so that iodine passes 
from the distillation flask to the collector without plating. Findings of this research suggest that 
Nuclear Science Center can now produce and recover iodine by a unique method and can 
compete with companies such as McMaster. 
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METHODS AND MATERIALS 
 
 
The research was divided into two phases: a non-radioactive phase to work out the 
details of the iodine chemistry and a radioactive phase to prove the principals developed in the 
first phase. Because stable I-127 and its radioactive isotopes share the same chemistry, chemical 
challenges anticipated in the production of iodine-125 were simulated with I-127 as closely as 
possible. Such a plan allowed working out the experimental details without the health concerns 
that would otherwise arise from working with radioactive iodine. Analytical procedures adapted 
in the non-radioactive phase included spectrophotometric analysis and analysis by neutron 
activation (NAA). Radioactive iodine-128 was used for experiments in the radioactive phase to 
corroborate the findings in the non-radioactive phase. Again, because the chemistry of all iodine 
isotopes is the same, iodine-128 was chosen as a suitable tracer. Iodine-128 has a 24.9 minutes 
half-life and is less hazardous than iodine-125 which has a 59.4 days half-life. Results obtained 
in radioactive phase were analyzed using gamma spectroscopy with high purity germanium 
detectors and GENIE 2000 software. 
 
ANALYTICAL METHODS APPLIED IN NON-RADIOACTIVE PHASE AND 
RADIOACTIVE PHASE 
 
Spectrometric analysis was used as a quick and easy way to determine the amount of 
recovered iodine during the initial stages of research. A Spectronic 20 was used for all 
spectrophotometric measurements. The spectrophotometer measures the concentration of the 
substance by measuring its absorbance or transmittance at a particular wavelength. The 
Spectronic 20 used in this project reports both percent transmittance and absorbance. Percent 
transmittance is the ratio of intensity of the light passing through the sample to the light incident 
on the sample multiplied by 100. Absorbance is described by Beer-Lambart’s Law shown in 
Equation 7, where A is the absorbance, Io is the intensity of the incident light, and I1 is the 
intensity of the light after passing the material. Absorbance is the log of transmittance. 
 A I Io= log ( )10 1                                                                               (7) 
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The Spectronic 20  instrument is shown in Figure 8. The control knobs are black and the 
meter has a mirror scale graduated from 0-100% in 1% divisions and from 0 to infinite optical 
density (logarithmic scale is in red). The wavelength scale is graduated from 350nm-1000 nm by 
5nm increments with numbered major divisions every 10nm. The wavelength control knob lies 
on top of the spectrophotometer while the zero control and the 100% transmittance control lie on 
the front panel. 
 
 
 
Figure 8 Spectrophotometer spectronic 20. 
 
 
In order to measure the iodine concentration in a sample the maximum absorption 
wavelength of iodine had to be determined. The maximum absorption wavelength was found by 
measuring a diluted standard iodine solution. The sample was measured at wavelengths between 
380nm to 650 nm. Before every measurement the machine was adjusted for 100 percent 
transmittance with a cuvette of deionized water. The absorbance for each of the wavelengths was 
noted and a plot of absorption versus wavelength was constructed using Excel. The wavelength 
at which the maximum absorption occurred was used to measure all iodine samples. 
A calibration curve was constructed for measuring iodine concentrations in the sample 
solutions. A standard solution of iodine was prepared using the method of Kolthoff and Sandell  
(Kolthoff et al. 1952) described later. A series of dilutions were prepared from the standard 
solution and their optical densities were measured at the maximum absorption wavelength of 
420nm. The data obtained were used to plot the change in optical density against iodine 
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concentration. A linear curve fit for the data points generated a linear equation, as expected, and 
the equation of this line was used to find the concentration of iodine in unknown solutions. 
Some experiments were also analyzed using neutron activation analysis. The reactor at 
the Nuclear Science Center was used activate sample solutions using a pneumatic system shown 
in Figure 9. During neutron activation I-127 undergoes an n, γ reaction to form I-128 and the 
activity of I-128 is compared against standards activated the same way to find the concentration 
of iodine.  
 
 
 
Figure 9 Pneumatic system at the laboratory of NSC. 
 
 
Using the pneumatic system, the samples were transport to reactor core position D2. 
There they were subjected to a thermal flux of about 1013cm-2sec-1 for about 1 min and then 
transported back to the laboratory receiver. All the samples were  homogenous and there were at 
least two representative sample units for a single sample. Since liquid samples could vaporize by 
thermal and radiation heating during irradiation, an expanse volume was included within the 
sample vials. Each sample vial (shown in Figure 10) was packed inside a bigger transfer vial. 
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The space between the sample vial and the mouth of transfer vial was packed with foam to 
maintain proper geometry during irradiation. A standard sample with a known amount of iodine 
was irradiated under the same conditions as the unknown sample solutions. Since the samples 
were irradiated for short period of time, the standard and the sample were exposed within few 
minutes of each other insuring negligible differences in the exposures.  
 
 
 
Figure 10 Pneumatic irradiation sample configuration. 
 
 
After activation the samples were counted to determine I-128 activity. Counting 
geometries were chosen to collect as many counts as possible while limiting dead time. Both the 
standard and the sample were counted on the same geometry and at same distance from the 
detector. The distance between the sample and the detector can be varied by using different 
stands as shown in Figure 11.  The GENIE2000 software was used for analyzing the data 
obtained from the detector. Besides the usual energy and absolute calibrations against NIST 
tracable sources, the simple ratio between the known and unknown samples gave the amount of 
I-128. 
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Figure 11 Stands of different heights for DET4. 
 
 
REAGENTS USED FOR ANALYSIS  
 
0.1N Sodium hydroxide (NaOH) solution: 1 ml of a 10N sodium hydroxide reagent 
solution from Sigma Aldrich was diluted with 99 ml of distilled water to prepare 0.1N sodium 
hydroxide solution. 
1N Hydrochloric acid (HCl): 4 ml of concentrated hydrochloric acid (36% w/w, ρ = 1.79 
gm.cc-1) from Merck was diluted with 46 ml of distilled water to prepare a solution of 1N 
hydrochloric acid. 
3% Hydrogen peroxide solution (H202): 3% grade hydrogen peroxide was used. 
0.01N Standard I-127 solution: 1.27 gram of reagent quality iodine was placed in a 250 
ml beaker. 4 grams of potassium iodide was added to it followed by 2.5ml water. The iodine was 
stirred occasionally to dissolve. When all the iodine had dissolved the solution was diluted to 
approximately 1liter.  
 Potassium iodide (KI) solution: 10 ml. of 10% (w/v) potassium iodide solution from 
Fisher Scientific was added to 90 ml of water to prepare a potassium iodide solution with 
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concentration of 10 milligrams of potassium iodide ml-1.1 ml of this was diluted with 9 ml of 
water to form KI solution with a concentration of 1 milligram of KI ml-1. 
 
EXPERIMENTAL METHODS ADAPTED FOR THE SECTROPHOTOMETRIC AND 
NEUTRON ACTIVATION ANALYSIS IN NON-RADIOACTIVE PHASE 
 
Few milligrams of natural iodine was carefully weighed into an aluminum canister. 
Figure 12 shows the aluminum canister that was used. About 0.5ml of water was added to the 
canister and the canister was heated with a hot air gun to about 180 C to allow the iodine vapors 
to react with the cylinder walls. The cylinder was allowed to cool and 10 ml of 0.1 N sodium 
hydroxide solution was added to the canister and the solution was left to equilibrate and then 
shaken to rinse the walls with sodium hydroxide. The washes were collected and the process 
repeated at least three times to ensure complete removal of the iodine from the canister. 
Throughout the text, the word ‘washing’ or ‘extracted solution’ has been used to refer to such 
cylinder washes. 
 
 
 
Figure 12 The aluminum cylinder. 
 
 
Possible reactions occurring in the extraction are given in Equations 8 and 9. 
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[ ]2 3 22 3 2 4NaOH Al O H O Al OH Na+ + → +− +( )                             (8) 
AlCl NaOH Al OH NaCl3 33 3+ → +( )                                               (9) 
To measure the iodine content, the iodide and the iodate ions in the washes were 
converted to I2 using hydrochloric acid. The aluminum hydroxide precipitate was dissolved 
using about 2 ml of 1N hydrochloric acid. 
 Since aluminum chloride is a Lewis acid, it reacts with the excess of sodium hydroxide 
to reform aluminum hydroxide. Therefore care was taken to completely neutralize the sodium 
hydroxide solution and to leave an excess of H+ ions in the solution. The H+ ions react with I- 
and IO3- according to Equation 10 to form elemental iodine. 
IO I H I H O3 2 25 6 3 3
−
− ++ + → +                                                     (10) 
 However, the chance of forming iodate from hypoiodite is usually quite low for such 
low concentration of sodium hydroxide. The chain of reactions preceding the formation of I- and 
IO- ions has been explained in Equation 4.                                                          
The excess acid changed the solution to orange-yellow, typical of free iodine.  The 
solution was well mixed and a 7 ml aliquot was transferred into a cuvette and the absorption 
measured at 420nm. To account for the interference from aluminum and sodium ions, blanks 
were prepared. For the blanks, the aluminum canisters were washed using 10ml of 0.1N sodium 
hydroxide, 2ml of 1N HCl was added to the wash and stirred. This dissolved the aluminum 
hydroxide precipitate and provided a clear solution. The solution was then well mixed and a 7 ml 
aliquot was used as the blank. The transmittance was set to 100% for the blank and the test 
solutions measured against this blank. The optical density was noted and the concentration of the 
sample was calculated using the iodine calibration curve. This process was repeated several 
times with 5 and 6 milligrams of iodine in aluminum cylinder to examine the accuracy of the 
experimental results. 
Distillation: Distillation was carried out with solutions extracted from aluminum 
cylinders. NAA was performed on the distillate and the results were used to calculate the amount 
of iodine in the distillate. Comparison of the iodine in the distillate to the amount of iodine 
weighed into the aluminum cylinder gave the percentage recovery of iodine. Table 6 sets forth 
the NAA results for the extracted solution. Another set of distillations (Table 7) was carried out 
with potassium iodide solution instead of the extracted solution. The exact amount of iodine in 
the initial solution must be known in order to calculate the percentage iodine recovery by the 
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process of distillation alone. To avoid the error associated with weighing milligram quantities of 
iodine into aluminum cylinders, a volumetric approach was adapted. A potassium iodide solution 
was prepared according to the procedure described before and the iodide in KI was converted to 
iodine using acidified solution of hydrogen peroxide. Hydrogen peroxide reacts with iodide 
according to Equation 3 Since 1gram of potassium iodide results in 0.76 gram of iodide ions; 
about 1ml of the prepared KI solution having about 0.76 milligrams of iodide was transferred 
into the distillation flask with an automated pipette. Ten ml of sodium hydroxide solution 
washed out from empty aluminum canisters was added to replicate the presence of aluminum 
hydroxide and sodium ions expected to be present in the washes during actual I-125 production. 
About 3 ml of 1N HCl was then added to neutralize the alkali and make the solution acidic. 
Under acidic condition the iodide is converted to elemental iodine following Equation 3.The 
volume was made up to about 24 ml and a distillation unit as shown in Figure 13 was assembled 
to distill the iodine over into a 50 ml round bottom flask.  
 
 
 
Figure 13 The distilling unit. 
 
 
Distillation was carried out using Sigma Aldrich’s mini distillation kit and a special 
order condenser. The heating mantle showed in the picture is from Glass-Kol and is used with a 
  
28 
variac to control the heating rate. During distillation of iodine there was no forced cooling (water 
flow) through the condenser. Heat was removed from the distillation head with wet tissue paper 
occasionally. Care was taken to maintain a high temperature inside the distillation unit to prevent 
the condensation of iodine on the walls of the distillation head or the condenser. The small 
plastic beaker (Figure 13) holding the collector vessel was filled with liquid nitrogen. The liquid 
nitrogen created a very low temperature inside the collector vessel and this allowed the iodine 
vapors to be drawn in quickly to the collector vessel once there was enough vapor pressure 
inside the distillation flask. The variac was maintained at a 130 V for the initial 12 minutes of 
distillation but was turned down 110V once there was enough vapor pressure inside the flask. At 
the end of distillation, the distillate was collected and 0.01N potassium hydroxide solution was 
added to provide a homogenous solution of I- ions for ease of sampling. 
NAA of distillate: At the end of distillation, 0.1 ml aliquots of the distillate were 
transferred into the small polyethylene vials shown in Figure 11 and packed as described before. 
Two such vials were prepared for a single set of distillate and analyzed by activation. The vials 
were irradiated in the core for about 1 min. A standard sample having a known amount of iodine 
was prepared and analyzed also. The activated samples were counted with HPGe detectors in 
standard geometries.  
Once the constituents of sample were identified the activity of I-128 was obtained from 
the spectrum setting the appropriate region of interest. The software calculates the activity for 
the sample acquisition time and corrects for decay while counting.  
The concentration of I-128 was estimated from the specific activities for the sample and 
the standard as shown in Equation 11. Csam and Cstd are the amounts of the sample and standard 
respectively. Asam denotes the specific activity of the sample and Astd is the specific activity for 
the standard. 
C A
A
Csam sam
std
std= .                                                                                 (11) 
The estimated concentration of I-128 was for the mass of sample solution in the vial. 
Adjusting it to the total weight of the distillate collected gave us the amount of iodine that could 
be recovered following distillation. A sample calculation for the above has is explained in 
Appendix A. 
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EXPERIMENTAL METHODS APPLIED FOR GAMMA SPECTROSCOPY IN THE 
RADIOIACTIVE PHASE 
 
Distillation was carried out with a radioactive tracer. A glove box as shown in Figure 14 
was used for distilling radioactive iodine. 1 ml of 20 milligrams potassium iodide sample 
solution was activated using neutron activation. After 1 min irradiation, neutron activation 
produced trace quantities of iodine-128.After sufficient decay time the sample was analyzed in a 
HPGe detector using GENIE 2000 software. The sample acquisition time was noted and the 
activity was recorded after correcting to the end of irradiation time following equation in 
Appendix B. For distillation, 0.5 ml of the irradiated potassium iodide solution was transferred to 
a glass vial filled with 4ml of sodium hydroxide solution .The solution was again counted using 
point source geometry and appropriate efficiency data. The time of acquisition was noted and the 
activity was recorded after correcting to the end of irradiation time for the sample. Thereafter the 
solution was transferred to a distillation flask followed by addition of 0.1 ml of 1N HCl acid and 
0.5 ml of 3% hydrogen peroxide. The peroxide oxidized the iodide into iodine and gave the 
solution a rich yellow color. 
 
 
 
Figure 14 Glove box used to carry out distillation of radioactive iodine. 
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Distillation was carried out and about 7 ml of distillate was collected in a 50ml round 
bottom flask with a diameter of 2.4 inches. In order to ensure a uniform distribution of iodine, 
few milliliters of 0.1 N sodium thiosulfate solution was added to the distillate. The whole 
distillate in the flask was counted on a 24 inch stand which placed the source (distillate) at a 
distance of 24 inches from the face of the detector. The efficiency calibration file for 24 inch 
stand was loaded into the sample spectrum before counting. Counting was carried out for 10 
mins, the acquisition time was noted and corrected to the end of irradiation time for the sample. 
Two sample vials with 0.1 ml of the distillate were also counted to substantiate the results from 
whole distillate counting. Comparison of the activities for the distilling solution and the distillate 
provided an estimate of the recovered iodine in the distillation. 
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RESULTS 
 
 
 
The transmittance as a function of wavelength was measured using a diluted standard 
solution of iodine. The transmittance was converted to absorbance by taking the logarithm of the 
transmittance and Figure 15 shows a plot of these measurements.  Inspection shows 420 nm to 
be the maximum absorption wavelength for the iodine solution. 
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Figure 15 Plot of optical density versus wavelength for iodine solution. 
 
 
A calibration curve was constructed using 420 nm and differing concentrations of iodine 
solutions. Table 4 shows the different concentrations of the standard iodine solutions that were 
measured. Percent transmittance was measured for each concentration and the absorption was 
calculated as before. Because absorbance varies directly as the concentration, a linear curve fit 
the data points. The graph generated in Figure 16 shows the linear equation for the plot. 
Concentration of iodine for unknown samples was measured using the plot. 
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Table 4 Absorbance versus iodine concentration. 
Absorbance
Measured 
iodine 
concentration 
(µg/7ml).
1.045 889
1 825.2
0.959 762
0.92 698
0.886 635
0.795 571.5
0.769 508
0.6989 381
0.638 317
0.585 254
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Figure 16 Iodine calibration curve. 
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To measure iodine content in extracted solution from aluminum cylinders, the 
absorbance for the particular solution was recorded following procedures described above. The 
amount of iodine was calculated using the linear equation in the above plot. At least three 
replicate measurements were recorded for each experimental run and the average of the three 
was taken as the expected concentration of iodine. This value, adjusted for the total volume of 
the extracted solution, was the total amount of iodine that was washed out. Experiments were 
repeated with 5 and 6 milligrams of I-127. Table 5 shows the percent recovery of iodine 
following spectroscopic measurements. A more explicit table for the process is shown in 
appendix C.  
 
 
Table 5 Recovery of iodine versus initial mass (measured by spectrometry). 
Experiment 
no.
Initial mass of 
iodine  in 
cylinder (mg)
Recovered 
amount of 
iodine in 
washout (mg)
Percent 
recovery of 
iodine
Average 6.03 5.120 84.86
Average 5.04 4.397 87.28
6.10
6.02
6.01
6.00
5.00
5.13
5.02
5.00
4.89
4.37
4.86
5.52
4.89
5.19
8.00 4.24
4.11
1.00
2.00
3.00
4.00
5.00
6.00
7.00
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Iodine extracted from the aluminum cylinder was also measured using neutron activation 
analysis. The extracted solution was distilled and NAA was performed on the distillate. Table 6 
shows the recovery percent following distillation. Minor details of the experiment are shown in 
appendix D. For neutron activation, two sample vials having 0.1 ml of distillate (represented by 
‘D’ in appendix D) were transported into the reactor core by pneumatic system, irradiated for 1 
minute and counted using the Genie2000 software. The activity was recorded. A standard KI 
solution with a known amount of iodine was also irradiated. The average of the specific activities 
for distillates (D) was compared with the average of the specific activities of KI standard 
(represented by KI Std.I and KI Std.II in appendix D). The amount of iodine in the sample vials 
was deduced using Equation 11. Concentration of iodine for the total volume of distillate was 
calculated by multiplying by the ratio of total distillate volume and aliquot volume. This 
provided for a measure of the amount of iodine recovered following the process of washing and 
distillation.  
 
 
Table 6 Recovery of iodine following distillation of extracted solution 
(measured by NAA). 
Average 6.995 5.078 72.591
Average 5.007 3.793 75.76
5.012
5.001
5
6
Recovered amount 
of  iodine in total 
volume of distillate 
(mg)
6.99
Experiment  
no.
5.066
3.576
Percent recovery of 
iodine
Amount of 
iodine weighed 
into aluminum 
cylinders (mg)
2
3
7.001
6.995
1 72.448
5.254
4.914
4.010
71.514
80.005
70.249
75.023
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A new set of experiments was conducted to establish the percent recovery of iodine by 
distillation alone. Iodide in potassium iodide solution was converted to iodine using hydrogen 
peroxide and distilled. Table 7 is the recovery percent of the distillation. An explicit table for the 
experiments has been shown in Appendix E. The letter S in the appendix represents the solution 
of potassium iodide used for distillation and the letter D stands for distillate. The distillate 
collected was made up to the same volume as the KI solution used for distillation. This made it 
easy to compare the specific activity of the solution and the distillate after NAA. NAA was done 
with two representative sample vials (having 0.1 ml) from each of ‘S’ and ‘D’. A standard 
sample with known quantity of iodine (KI std.I and KI std. II ) was used for calculating iodine 
amount in the distillate and solution. Relative iodine concentration in total volume of sample and 
distillate provided the percent recovery of iodine.  
 
 
 
Table 7 Iodine recovery from distilling I-127 in potassium iodide solution 
 (measured by NAA). 
Experiment no.
Measured 
initial mass of 
iodine in KI 
solution (mg) Standard error 
Recovered 
mass of 
iodine in 
distillate 
(mg)
Standard 
error
Percent 
recovery
Error in 
percent 
recovery
1 1.13E+00 4.62E-02 1.05E+00 4.46E-02 9.30E+01 5.50E+00
2 1.09E+00 4.48E-02 1.01E+00 4.26E-02 9.34E+01 5.49E+00
3 1.11E+00 4.64E-02 9.79E-01 4.12E-02 8.85E+01 5.26E+00
4 1.11E+00 4.70E-02 9.50E-01 3.87E-02 8.53E+01 5.00E+00
Average 1.11E+00 9.98E-01 9.00E+01
 
 
 
Experiments for the radioactive phase were carried out with an I-128 tracer. Table 8 
shows the recovery for distillation carried out using this tracer. Four experiments were carried 
out with initial masses of iodine. The recovery percent for the different masses is shown in Table 
8. Details for each experiment are in Appendices  F, G, H and I. For each of the four radioactive 
experiments, 1 ml of known quantity of potassium iodide was irradiated. This formed trace 
quantities of iodine-128.A few milliliters of this iodine solution with tracer was then transferred 
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to a distillation flask to be distilled. This solution is the ‘potassium iodide solution for 
distillation’ in the appendices. From the measurement of the activities for each, the mass of 
iodine can be calculated. Distillation was carried out with the ‘KI solution for distillation’ and 
the distillates were counted and compared by two different methods. Counting two aliquots 
designated ‘Distillate-I’ and ‘Distillate-II’ was one way of measuring the activity for the whole 
distillate. The other was counting the entire volume of distillate in a round bottom flask (D-24). 
To maintain point source geometry the flask was placed about 24 inches away from the face of 
the detector. All activities were corrected to the end of irradiation time. Comparison of the total 
mass of iodine in KI solution with the amount of iodine in total mass of distillate specified the 
percent recovery of iodine through distillation.
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Table 8 Recovery of iodine from distillation of I-128 tracer in KI solution (measured by gamma spectroscopy). 
D1 and D2 D-24 D1 and D2 D-24
1 7.60E+00 4.34E-01 6.95E+00 3.89E-01 7.36E+00 4.35E-01 9.07E+01 9.38E+01 7.26E+00 7.96E+00
2 7.80E+00 2.45E-01 6.98E+00 5.58E-01 7.17E+00 4.88E-01 8.95E+01 9.19E+01 7.68E+00 6.89E+00
3 1.37E+01 4.40E-01 1.21E+01 9.89E-01 1.20E+01 5.95E-01 8.86E+01 8.75E+01 7.77E+00 2.82E+00
4 7.60E-01 2.02E-02 6.94E-01 0.0218454 7.09E-01 0.026739 9.13E+01 9.33E+01 3.76E+00 4.30E+00
Average 9.00E+01 9.16E+01
Measured 
mass from 
D-24 (mg)
Experiment 
No.
Recovered iodine in distillate 
Recovery percent Percent error in 
recovery
Initial iodine in KI solution
Measured mass 
(mg) Standard error
Average mass 
from D1 and 
D2 (mg)
Standard 
error 
Standard 
Error 
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DISCUSSION 
 
 
 
This research focused on testing a novel I-125 recovery technique. Using aluminum 
cylinders for irradiation and using distillation as a purifying procedure are relatively new ideas in 
the field of iodine-125 production. Results suggest both ideas work well in terms of productivity 
and simplicity. Sodium hydroxide can be used as an extracting solvent in spite of its reactivity 
with the aluminum walls.  
Spectrometry was used to quantify the amount of iodine that was extracted with sodium 
hydroxide. This was a quick, simple way of estimating percent iodine recovery. Experiments 
were conducted with relatively large amount of iodine owing to the difficulty in measuring very 
small amounts of solid iodine. Percent recovery was checked for differing masses of I-127 in the 
cylinder. The average iodine content in aluminum wash for an average initial amount of 6.01 
milligram (Table 5) is 5.12 milligrams with a standard deviation of 0.301 milligrams. This shows 
an average recovery of about 84 percent. Recovery is 87 percent for an average initial amount of 
5 milligrams. But, it is difficult to quantify the exact amount of iodine weighed into the 
cylinders. Calibration data suggest the OHAUS balance has at least 20 percent error in reporting 
milligram quantities of material. Apart from the volatility of iodine which can cause an error in 
weighing, there is al least 20 percent error in the weights of iodine recorded by OHAUS. This is 
likely to change the calculation of percent recovery. Considering 20 percent error, the percent 
recovery for the average initial amount of 5 milligrams probably ranges from 83 percent to 90 
percent. For the same reason, the percent recovery for the initial amount of 6.01 milligrams 
ranges from 82 percent to 87 percent. 
Iodine content in the extracted solution was also measured by NAA. The washout was 
distilled and NAA of the distillate was performed. This was an indirect way of estimating the 
iodine amount. A more direct way would be neutron activation of the solution itself, but the 
extracted solution was inhomogeneous and created considerable difficulty in sampling. As 
before, recovery percent was checked for differing quantities of iodine in the cylinder. The 
amount of iodine in the distillate was compared to the initial amount of iodine that was weighed 
into the cylinders. Table 6 shows that for an average of 7.11 milligrams of iodine the recovery is 
5.07 milligram, which is about 72 percent. But the rest 30 percent loss includes the loss incurred 
in cylinder washing as well as the loss in distillation. It was important to know the loss incurred 
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in each of the processes. A new set of experiments was conducted to assess the recovery percent 
for distillation alone. Table 7 suggests that the percent recovery of iodine for distillation is quite 
high. Examination of all four experiments indicates that recovery varies from 85 percent to 93 
percent. This varying range is likely because of variation in the process of distillation rather than 
any statistical error in the measurements. As shown in Appendix E, the standard error in the 
specific activity of the distilling solution and the distillate is largely consistent and centers 
around 3 percent. Error propagation shows that the error associated with measured iodine content 
in the distillate is reasonably low and is within 1 percent. The error in percent recovery for all 
four experiments in Table 7 is also remarkably consistent. Any noteworthy difference in 
recovery has therefore resulted from the process of distillation itself. Nevertheless, if the mean 
iodine content in the solution (Table 7) is compared to the mean iodine content in the distillate 
the overall recovery percent by distillation is about 90%.  
Although it is difficult to avoid the inherent variation between any two distillations, 
careful distillation promises even higher yield. The chemical nature of iodine causes it to plate 
on the surface of the condenser while passing from distillation flask to the collector vessel. The 
non-radioactive phase was designed to work out such details associated with iodine chemistry. 
Experimental trials in the course of the research have shown that plating can be prevented by 
controlling the temperature in the condenser during the course of distillation. The usual practice 
for a typical distillation is to allow water jacketed cooling of the condenser. This ensures 
condensation of the vapors and prevents bursting of the distillation head from excessive vapor 
pressure. But iodine would plate on the walls of the condenser under such circumstances. 
Distillation techniques were therefore modified to suit this research. Distillation was performed 
without any forced cooling of the condenser; instead the collector vessel was placed on liquid 
nitrogen. The intention was to bring down the temperature inside the collector vessel so that the 
iodine vapors get drawn into the collector vessel driven by high pressure in the distillation flask. 
The liquid nitrogen also condensed the vapors once it reached the collector vessel. Adjustments 
were also made for a suitable distillation head. Figure 17 below shows a two way distillation 
adapter placed vertically into the distillation flask. Iodine distillation is difficult with a vertically 
placed distillation head. Because the vapor pressure of iodine increases rapidly with temperature, 
as distillation proceeds, a sudden high pressure is created inside the distillation head. This exerts 
enough pressure on the lid to make it act as a safety valve release, causing huge loss of iodine.  
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Figure 17 Distilling unit not suitable for iodine distillation. 
 
 
 Placing the distillation head horizontally as in Figure 18 prevents such bursting. Also, a 
narrow mouthed adapter attached with a needle (Figure 17) is not suitable for collection of 
iodine. Since iodine immediately transforms from the vapor phase to the solid phase, any narrow 
passage on its course allows the element to plate. The best alternative to a needle is therefore a 
wide mouthed condenser tube connecting the distillation head directly to the collector vessel 
through ground joints. This ensures a wide passage for the iodine vapors and prevents any loss. 
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Figure 18 Distillation unit used for iodine distillation. 
 
 
Once these details were worked out, experiments were conducted with iodine-128 tracer. 
The results for radioactive iodine distillation strongly corroborate the data for non-radioactive 
iodine distillation. The experiments were the same as that used in non-radioactive phase. Four 
sets of distillation were carried out with differing quantities of initial iodine (Tables 8, 
Appendices F,G,H and I). The results from all four suggest that recovery percent of iodine 
ranges from 88 to 96. For each experiment, two types of measurements were made. Counting 
two aliquots, designated ‘Distillate-1’ and ‘Distillate-2’ was one way of measuring the activity 
for the whole distillate. The other was counting the whole volume of distillate (named D-24) 
maintaining a point source geometry. Appendices F,G, H, I gives a detailed insight into how 
these measurements were made. Note, however, that there is a difference in the percent recovery 
calculated by the above two ways for the same amount of iodine distilled. For example, in 
experiment 1, the recovery percent for D-24 is 96 but the recovery percent for D1 and D2 is 90. 
Such difference exists for all four experiments done with I-128 tracer. It may have been caused 
by the difference in aliquot size for the two vials or because of error associated with weighing 
the vials. Since the average quantity of iodine (measured by D1 and D2) was dependent on the 
specific activities of the representative sample vials, any small difference in recorded sample 
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mass for D1 and D2 could have caused a difference in calculation of specific activity. This 
would eventually make a difference in calculating average quantity of iodine. The measurements 
for D-24 were for the whole distillate and were free of such possibilities. D-24 therefore 
provided a better accuracy in iodine estimation. 
In conclusion it can be said that higher yield of radioactive iodine is possible with simple 
distillation. The procedure for distillation is simple and can be carried out safely in a glove box. 
Spectroscopic data suggests that the distillate obtained is 100 percent pure iodine. There is no 
evidence to show that recovery varies with initial iodine mass. Recovery can be high with 
masses as high as 7.6 mg (Appendix F and I) and as low as 0.76 mg. Moreover, distillation can 
concentrate the amount of iodine extracted from the cylinders. A careful observation of the data 
presented in appendix F, G and H bears proof to the concentration achieved by distillation. The 
mass of the distillate collected is much less than the mass of the solution that was used for 
distilling. For experiment 1 in Appendix F, a mass of 38 grams of initial distilling solution 
resulted in 12 grams distillate. This shows that distillation can reduce the solution to almost one 
third or less of its original volume. The concentrated iodine can now be dissolved in buffered 
solution and the concentration can be adjusted based on market demands. Although the present 
research could not provide any conclusive evidence for the amount of iodine in the extracted 
solution results suggest that the recovery of iodine in the extracted solution is at least 84%. 
Future work with iodine-125 can provide more convincing data on the process. 
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CONCLUSION 
 
 
 
There is a demand for iodine-125 in the present market. The present I-125 production 
companies suffer from certain problems that can be overcome using the results of this research. 
Using aluminum irradiation cylinder can reduce irradiation time for Xe-124 and this reduced 
irradiation time will help minimize I-126. Iodine in these aluminum cylinders can be extracted 
using sodium hydroxide. The concentration of the iodine can be increased by distillation. Thus 
distillation is a suitable means for both purifying and concentrating iodine-125.  Distillation can 
reduce the extracted solution to one third or less of its original volume. The recovery percent of 
iodine during distillation ranges from 88 to 96 but careful distillation promises even higher 
recovery. There is no evidence to show that recovery varies with varying mass. Recovery can be 
high with mass as high as 7.6 milligrams (Appendix F) and mass as low as 0.76 milligram 
(Appendix I). The difference in recovery is mostly because of the process of distillation itself 
and not because of any statistical error in measurement. Distillation for I-125 differs slightly than 
conventional techniques. No forced cooling of the condenser is necessary during distillation, for 
example.  
Although results indicate that extraction of iodine is possible with sodium hydroxide this 
research could not provide conclusive evidence for the amount of iodine extracted. 
Spectrometric results suggest that recovery percent is high and is at least 84. But better analytical 
means are necessary to quantify the exact amount of iodine in the extracted solution. Making I-
125 in the reactor and extracting it using procedures discussed in this work will help in better 
analysis. The whole process of extraction and distillation needs to be automated for large scale 
production. The tested principles should be applied on an industrial scale for successful 
production of iodine-125. 
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APPENDIX A 
 
 
SAMPLE CALCULATION OF I-128 CONCENTRATION FROM SPECIFIC ACTIVITY 
 
M A
A
Msam sam
std
std= .  = 
7 20 1
216 2
0152.
.
* .
E
E
+
+
 = 0.051 
Here Msam and Mstd are the mass of the sample and standard respectively. Asam denotes 
the specific activity of the sample and Astd is the specific activity for the standard. 
 
 
S.N Sample ID Type
Sample mass 
(mg)
Irradiation 
time
 (sec)
Counting 
time
(sec)
Amount of 
iodine in 
sample 
mass (mg)
Wt. mean Error
KI Std I KI Std 100.5000 60 240 2.19E+02 4.97E+00
KI Std II KI Std 100.9000 60 240 2.13E+02 3.76E+00
2.16E+02 4.36E+00 1.52E-01
10 7.40E+01 0.052 5.208
10 7.00E+01 0.049 4.924
7.20E+01 0.051 5.066 72.448
1
 Specific 
activity for 
measured 
volume of  
distillate
(µCi/g)
 Iodine 
content 
in total 
volume 
of 
distillate 
(mg)
Total volume 
of distillate 
collected (ml)
6.99
S.N
Amount 
of iodine 
in 
measured 
volume of 
distillate 
(mg)
Average iodine content in D-1
Average specific 
activity of I
(µCi/g)
1
Average iodine content in potassium iodide standard
Percentage 
recovery of 
iodine
Amount of 
iodine 
weighed into 
aluminum 
cylinders 
(mg)
Average of 
iodine 
content in 
total 
volume of 
distillate 
(mg)
Average 
of iodine 
weighed 
in 
aluminum 
cylinders 
(mg)
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APPENDIX B 
 
 
SAMPLE CALCULATION FOR ACTIVITY CORRECTION TO END OF 
IRRADIATION TIME 
 
A A eo
t
=
−λ
 
→ =
+
− −
A
e
E
e
tλ
852 2
0 693
25 47
.
. *
= 3.10E+3 
Where A is the activity at the time of sample acquisition, Ao is the activity at the end of 
irradiation time for the sample, λ is the disintegration constant, t is the time difference between 
end of irradiation time and acquisition time. The acquisition time for example below is 10:18 
AM and the end of irradiation time is 9:31AM. 
 
 
Activity Uncertainty Activity Uncertainty
1
Irradiated 
KI soln. 0.9937 8.52E+02 2.16E+01 3.10E+03 7.87E+01
Specific activity 
(µCi/gm) at 9:31:29AM
Specific activity 
(µCi/gm) at 
10:18:02AM
Experiment 
number Sample ID
Mass used 
for analysis 
(g)
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APPENDIX C 
 
 
SPECTROMETRIC MEASUREMENT OF IODINE CONTENT IN EXTRACTED SOLUTION 
 
 
Experiment 
no.
Initial 
iodine 
mass in 
cylinder 
(mg)
Total 
cylinder 
wash (ml)
Volume 
of sample 
measured 
(ml)
No. of 
measurements
Optical 
density of 
sample
Iodine 
in 
sample
(mg)
Iodine 
mass in 
total 
cylinder 
wash (mg)
Standard 
error
 Mean of 
iodine mass 
in wash(mg)
 Mean of 
initial iodine 
mass in 
cylinder(mg)
Percent 
recovery of 
iodine
I 0.92 0.70 5.38
1 II 0.96 0.75 5.79
III 0.92 0.70 5.38
Average 5.52 0.13
I 0.85 0.62 4.78
2 II 0.85 0.62 4.78
III 0.89 0.66 5.09
Average 4.89 0.10
I 0.89 0.66 5.09
3 II 0.92 0.70 5.38
III 0.89 0.66 5.09
Average 5.19 0.10
I 0.89 0.55 5.09
4 II 0.85 0.55 4.78
III 0.85 0.55 4.78
Average 4.89 0.10
5.12 6.03 84.86
7.00
7.00
6.01 54.00 7.00
6.00 54.00 7.00
54.00
54.00
6.10
6.02
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Continued. 
 
 
Experiment 
no.
Initial iodine 
mass in 
cylinder 
(mg)
Total 
cylinder 
wash (ml)
Volume of 
sample 
measured 
(ml)
No. of 
measurements
Optical 
density of 
sample
Iodine in 
sample(mg)
Iodine mass 
in total 
cylinder 
wash (mg)
Standard 
error
 Mean of 
iodine mass 
in wash(mg)
 Mean of 
initial iodine 
mass in 
cylinder(mg)
Percent 
recovery of 
iodine
I 0.82 0.55 4.24
5 II 0.80 0.60 4.63
III 0.82 0.55 4.24
Average 4.37 0.13
I 0.85 0.62 4.78
6 II 0.85 0.62 4.78
III 0.89 0.65 5.01
Average 4.86 0.08
I 0.80 0.60 4.63
7 II 0.77 0.50 3.86
III 0.77 0.50 3.86
Average 4.11 0.26
I 0.82 0.55 4.24
8 II 0.82 0.55 4.24
III 0.82 0.55 4.24
Average 4.24 0.00 4.40 5.04 87.28
5.00 45.00 7.00
5.00 45.00 7.00
5.13 45.00 7.00
5.02 45.00 7.00
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APPENDIX D 
 
 
NAA OF DISTILLATE FROM DISTILLATION OF CYLINDER WASH 
 
 
S.N Sample ID Type
Sample mass 
(mg)
Irradiation 
time
 (sec)
Measuring 
time
(sec)
Amount of 
iodine in 
sample mass 
(mg)
 Wt. mean 
activity
Standard 
deviation
KI Std I KI Std 1.01E+02 6.00E+01 2.40E+02 2.19E+02 4.97E+00
KI Std II KI Std 1.01E+02 6.00E+01 2.40E+02 2.13E+02 3.76E+00
Average iodine content in potassium iodide 2.16E+02 4.36E+00 1.52E-01
Wt. mean 
activity
Standard 
error Amount(mg) Standard error
D-1a Distillate 1.00E+01 1.00E-01 1.02E+02 7.40E+01 1.63E+00 5.21E-02 1.55E-03 5.21E+00
D-Ib Distillate 1.00E+01 1.00E-01 1.04E+02 7.00E+01 1.73E+00 4.92E-02 1.57E-03 4.92E+00
7.20E+01 1.68E+00 5.07E-02 1.56E-03 5.07E+00 7.25E-01
D-IIa Distillate 1.15E+01 1.00E-01 1.05E+02 7.10E+01 1.55E+00 4.99E-02 1.49E-03 5.74E+00
D-IIb Distillate 1.15E+01 1.00E-01 1.05E+02 5.89E+01 1.31E+00 4.14E-02 1.25E-03 4.76E+00
6.49E+01 1.43E+00 4.57E-02 1.37E-03 5.25E+00 7.50E-01
D-IIIa Distillate 1.10E+01 1.00E-01 1.02E+02 7.29E+01 1.59E+00 5.13E-02 1.52E-03 5.64E+00
D-IIIb Distillate 1.10E+01 1.00E-01 1.06E+02 5.41E+01 5.70E-02 3.81E-02 7.70E-04 4.19E+00
6.35E+01 8.22E-01 4.47E-02 1.15E-03 4.91E+00 7.02E-01
5.08E+00 7.00E+00 7.26E-01
Average of  
iodine in 
distillate 
content(mg)
Average of 
initial iodine 
content in 
aluminum 
cylinders(mg)
Sample mass 
(mg)
Total iodine 
content in 
distillate 
volume(mg)
6.99E+00
1.00E+00
S.N
1.00E+00
Average iodine content in D-I
Average iodine content in D-II
Average iodine content in D-III
2.00E+00
3.00E+00
7.00E+00
7.00E+00
Percent 
recovery of 
iodineSample ID Type
Initial iodine 
content in 
aluminum 
cylinders 
(mg)
Sample 
volume for 
NAA (ml)
Iodine content
in sample volume (%)
 Specific activity of I
(µCi/g)
Total volume 
of distillate 
(ml)
Specific activity of I
(µCi/g)
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Continued. 
 
 
Wt. mean 
activity
Standard 
error Amount(mg) Standard error
D-IVa Distillate 1.40E+01 1.00E-01 9.95E+01 4.03E+01 9.95E-01 2.83E-02 9.05E-04 3.97E+00
D-IVb Distillate 1.40E+01 1.00E-01 1.01E+02 4.11E+01 9.93E-01 2.89E-02 9.11E-04 4.05E+00
4.07E+01 9.94E-01 2.86E-02 9.08E-04 4.01E+00 8.00E-01
D-Va Distillate 1.50E+01 1.00E-01 1.04E+02 3.10E+01 8.02E-01 2.18E-02 7.16E-04 3.27E+00
D-Vb Distillate 1.50E+01 1.00E-01 1.02E+02 3.68E+01 9.11E-01 2.59E-02 8.28E-04 3.88E+00
3.39E+01 8.57E-01 2.38E-02 7.72E-04 3.58E+00 7.15E-01
3.79E+00 5.01E+00 7.58E-01
6.00E+00 5.00E+00
Average iodine content in D-V
Percent 
recovery of 
iodine
5.00E+00 5.01E+00
Average iodine content in D-IV
Iodine content
in sample volume (%) Total iodine 
content in 
distillate 
volume(mg)
Average of  
iodine in 
distillate 
content(mg)
Average of 
initial iodine 
content in 
aluminum 
cylinders(mg)S.N
Initial iodine 
content in 
aluminum 
cylinders 
(mg) Sample ID Type
Total volume 
of distillate 
(ml)
Sample 
volume for 
NAA (ml)
Sample mass 
(mg)
 Specific activity of I
(µCi/g)
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APPENDIX E 
 
 
NAA RESULTS FROM DISTILLING NON-RADIOACTIVE IODINE 
 
 
Wt. mean 
activity Error
KI Std I KI Std 9.95E-02 5.91E+04 1.47E+03
KI Std II KI Std 9.96E-02 5.71E+04 1.43E+03
Average I Content in KI Std 5.81E+04 1.45E+03 1.20E-02
Wt. mean 
activity
Standard 
error Amount (mg)
Standard 
error
S Ia Solution 1.13E+00 2.40E+01 1.00E-01 1.00E-01 2.27E+04 7.35E+02 4.70E-03 1.92E-04
S Ib Solution 1.12E+00 2.40E+01 1.00E-01 1.00E-01 2.26E+04 7.41E+02 4.68E-03 1.93E-04
2.27E+04 7.38E+02 4.69E-03 1.92E-04 1.13E+00 4.62E-02
D-Ia Distillate 2.40E+01 1.00E-01 9.90E-02 2.10E+04 6.91E+02 4.34E-03 1.79E-04 1.04E+00
D-Ib Distillate 2.40E+01 1.00E-01 9.87E-02 2.12E+04 7.63E+02 4.38E-03 1.92E-04 1.05E+00
2.11E+04 7.27E+02 4.36E-03 1.86E-04 1.05E+00 4.46E-02 9.30E+01 5.50E+00
S IIa Solution 1.09E+00 2.40E+01 1.00E-01 9.89E-02 2.23E+04 7.24E+02 4.61E-03 1.89E-04
S IIa Solution 1.06E+00 2.40E+01 1.00E-01 9.79E-02 2.15E+04 7.14E+02 4.45E-03 1.85E-04
2.19E+04 7.19E+02 4.53E-03 1.87E-04 1.07E+00 4.48E-02
D-IIa Distillate 2.40E+01 1.00E-01 1.00E-01 2.14E+04 7.02E+02 4.43E-03 1.83E-04 1.06E+00
D-IIb Distillate 2.40E+01 1.00E-01 1.01E-01 1.95E+04 6.76E+02 4.03E-03 1.72E-04 9.67E-01
Average I Content in D-II 2.05E+04 6.89E+02 4.23E-03 1.77E-04 1.01E+00 4.26E-02 9.44E+01 5.59E+00
Error in 
percent 
recovery
Standard 
error
Percent 
recovery of 
iodine
Sample 
mass 
(g)
Sample 
ID Type
Sample mass 
(g) of 0.1 ml
Sample 
ID Type
 Specific activity of I
(µCi/g)
Amount of 
iodine
in 0.1 ml of 
Std.(mg)
Mass of 
iodine in 
distillate 
(mg)
 Specific activity of iodine
(µCi/g)
Mass of 
iodine in 
solution to be 
distilled (mg)
Total 
volume of 
solution to 
be distilled 
(ml)
Total 
volume of 
distillate 
collected  
(ml)
Sample 
volume for 
NAA (ml)
 Iodine Content
in sample 
Average I Content in Solution I
Average I Content in D-I
Average I Content in Solution II
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Continued. 
 
 
Wt. mean 
activity
Standard 
error Amount (mg)
Standard 
error
S IIIa Solution 1.11E+00 2.40E+01 1.00E-01 9.90E-02 2.21E+04 7.57E+02 4.56E-03 1.94E-04
S IIIa Solution 1.12E+00 2.40E+01 1.00E-01 9.79E-02 2.25E+04 7.45E+02 4.65E-03 1.93E-04
2.23E+04 7.51E+02 4.61E-03 1.93E-04 1.11E+00 4.64E-02
D-IIIa Distillate 2.40E+01 1.00E-01 9.75E-02 1.72E+04 6.14E+02 3.55E-03 1.55E-04 8.51E-01
D-IIIb Distillate 2.40E+01 1.00E-01 9.86E-02 2.23E+04 7.20E+02 4.61E-03 1.88E-04 1.11E+00
1.97E+04 6.67E+02 4.08E-03 1.71E-04 9.79E-01 4.12E-02 8.81E+01 5.22E+00
S IVa Solution 1.11E+00 2.40E+01 1.00E-01 9.80E-02 2.24E+04 7.57E+02 4.63E-03 1.95E-04
S IVb Solution 1.11E+00 2.40E+01 1.00E-01 9.78E-02 2.25E+04 7.69E+02 4.65E-03 1.97E-04
2.25E+04 7.63E+02 4.64E-03 1.96E-04 1.11E+00 4.70E-02
D-IVa Distillate 2.55E+01 1.00E-01 1.00E-01 1.95E+04 6.80E+02 4.03E-03 1.73E-04 1.03E+00
D-IVb Distillate 2.55E+01 1.00E-01 1.00E-01 1.66E+04 5.92E+02 3.42E-03 1.49E-04 8.73E-01
Average I Content in D-V 1.80E+04 6.36E+02 3.73E-03 1.61E-04 9.50E-01 3.87E-02 8.53E+01 5.00E+00
Error in 
percent 
recovery
Average I Content in Solution IV
Average I Content in D-IV
Average I Content in Solution V
 Iodine Content
in sample 
Mass of 
iodine in 
distillate 
(mg)
Standard 
error
Percent 
recovery of 
iodine
Total 
volume of 
distillate 
collected  
(ml)
Sample 
volume for 
NAA (ml)
Sample 
mass 
(g)
 Specific activity of iodine
(µCi/g)
Sample 
ID Type
Mass of 
iodine in 
solution to be 
distilled (mg)
Total 
volume of 
solution to 
be distilled 
(ml)
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APPENDIX F 
 
 
DISTILLATION OF I-128 IN EXPERIMENT 1 
 
 
Activity Uncertainty Activity Uncertainty
Irradiated 
KI soln. 9.94E-01 1.52E+01
36 inch stand 
point source 3.10E+03 7.87E+01 3.08E+03 7.87E+01
Soln. for 
distillation 3.86E+01 4.97E-01 7.60E+00 1.55E+03 7.87E+01 1.54E+03 7.87E+01
Distillate in 
vial  D1 1.20E+01 9.70E-02
Stand 1 point 
source 1.23E+02 4.70E+00 1.47E+03 5.65E+01 7.27E+00 3.35E-01 7.60E+00
Distillate in 
vial  D2 1.20E+01 9.70E-02
Stand 1 point 
source 1.12E+02 4.84E+00 1.34E+03 5.82E+01 6.62E+00 4.44E-01 7.60E+00
6.95E+00 3.89E-01 7.60E+00 9.07E+01
Distillate in 
round 
bottom flask 
D24 1.20E+01 1.20E+01
24 inch stand 
point source 1.49E+03 7.96E+01 7.36E+00 4.35E-01 7.60E+00 9.68E+01
Total mass of 
the solution that 
was distilled(g)
Mass used 
for 
analysis 
(g)
Counting 
geometry
Specific activity (µCi/gm) 
at 9:31:29AM
Percent 
recovery 
of iodine
 Iodine 
content 
(mg)
Average iodine content
Sample ID
Total 
mass of 
distillate 
collected 
(g)
Recovered 
amount of 
iodine  in 
total mass of 
distillate 
(mg)
Expected 
iodine 
content in 
total mass 
of distillate 
(mg)
Standard 
error
Total activty (µCi) at 
9:39:29AM
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APPENDIX G 
 
 
DISTILLATION OF I-128 IN EXPERIMENT 2 
 
 
Activity Uncertainty Activity Uncertainty
Irradiated 
KI-II soln. 1.00E+00 1.52E+01
24 inch point 
source 1.80E+03 4.02E+01 1.80E+03 4.02E+01
 Soln. for 
distillation 3.93E+01 5.21E-01 7.80E+00
Stand 5 point 
source 1.80E+03 4.02E+01 9.36E+02 2.07E+01
Distillate in 
vial  D1 1.36E+01 9.70E-02
Stand 1point 
source 6.19E+01 4.94E+00 8.41E+02 6.70E+01 7.09E+00 5.87E-01 7.80E+00
Distillate in 
vial  D2 1.36E+01 9.40E-02
Stand 1point 
source 6.06E+01 4.47E+00 8.24E+02 6.07E+01 6.87E+00 5.29E-01 7.80E+00
6.98E+00 5.58E-01 7.80E+00 8.95E+01
Distillate in 
round 
bottom flask 
D24 1.36E+01 1.36E+01
24 inch point 
source 8.51E+02 5.47E+01 7.17E+00 4.88E-01 7.80E+00 9.19E+01
Total mass of 
the solution that 
was distilled(g)
Counting 
geometry
Total activty (µCi) at 
10:34:00 AM
Recovered 
amount of 
iodine  in 
total mass of 
distillate 
(mg)
Total 
mass of 
distillate 
collected 
(g)
Mass of 
sample 
analyed 
(g)
 Iodine 
content 
(mg)
Standard 
error
Expected 
iodine 
content in 
total mass 
of distillate 
(mg)
Percent 
recovery 
of iodine
Average iodine content
Specific activity (µCi/gm) 
at 10:34:00 AM
Sample ID
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APPENDIX H 
 
 
DISTILLATION OF I-128 IN EXPERIMENT 3 
 
 
Activity Uncertainty Activity Uncertainty
Irradiated 
KI-III soln. 9.84E-01 1.52E+01
36 inch stand 
point source 3.70E+03 8.93E+01 3.63E+03 8.78E+01
 Soln. for 
distillation 4.60E+01 8.85E-01 1.37E+01
Stand 5 point 
source 3.70E+03 8.93E+01 3.27E+03 6.94E+01
Distillate in 
vial       D1 1.69E+01 1.00E-01
Stand 1point 
source 1.65E+02 1.24E+01 2.79E+03 2.09E+02 1.17E+01 9.19E-01 1.37E+01
Distillate in 
vial  D2 1.69E+01 9.80E-02
Stand 1point 
source 1.78E+02 1.45E+01 3.01E+03 2.45E+02 1.26E+01 1.06E+00 1.37E+01
1.21E+01 9.89E-01 1.37E+01 8.86E+01
Distillate in 
round 
bottom flask 
D24 1.69E+01 1.69E+01
24 inch point 
source 2.86E+03 1.24E+02 1.20E+01 5.95E-01 1.37E+01 8.75E+01
Total mass of 
the solution that 
was distilled(g)
Total 
mass of 
distillate 
collected 
(g)
Mass of 
sample 
analyed 
(g)
 Iodine 
content 
(mg)
Standard 
error
Expected 
iodine 
content in 
total mass 
of distillate 
(mg)
Percent 
recovery 
of iodine
Counting 
geometry
Average iodine content
Specific activity (µCi/gm)  
at 10:31:23 AM
Total activty (µCi) at 
10:31:23 AM
Sample ID
Recovered 
amount of 
iodine  in 
total mass of 
distillate 
(mg)
 
 
 
 
  
57
APPENDIX I 
 
 
DISTILLATION OF I-128 IN EXPERIMENT 4 
 
 
Activity Uncertainty Activity Uncertainty
Irradiated 
KI-II soln. 9.99E-01 1.00E+00
Stand 5 point 
source 2.34E+02 4.09E+00 2.34E+02 4.09E+00
 Soln. for 
distillation 4.01E+01 7.69E-01 7.70E-01
Stand 5 point 
source 2.34E+02 4.09E+00 1.74E+02 3.64E+00
Distillate in 
vial       D1 1.57E+01 9.70E-02
Stand 1point 
source 9.10E+00 3.80E-01 1.43E+02 5.96E+00 6.32E-01 2.86E-02 7.70E-01
Distillate in 
vial  D2 1.57E+01 9.40E-02
Stand 1point 
source 1.04E+01 3.82E-01 1.63E+02 5.99E+00 7.21E-01 3.05E-02 7.70E-01
6.77E-01 2.96E-02 7.70E-01 8.79E+01
Distillate in 
round 
bottom flask 
D24 1.57E+01 1.57E+01
24 inch point 
source 1.62E+02 5.09E+00 7.18E-01 3.48E-02 7.70E-01 9.33E+01
Standard 
error
Expected 
iodine 
content in 
total mass 
of distillate 
(mg)
Percent 
recovery 
of iodineSample ID
Total mass of 
the solution that 
was distilled(g)
Total 
mass of 
distillate 
collected 
(g)
Mass of 
sample 
analyed 
(g)
 Iodine 
content 
(mg)
Counting 
geometry
Specific activity (µCi/gm)  
at 10:12 AM
Total activty (µCi) at 
10:12AM
Recovereda
mount of 
iodine  in 
total mass of 
distillate 
(mg)
Average iodine content
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